Fennec Pharmaceuticals (FENC)

• Market cap: $257M
• 1 day: -1.44%
• 5 days: -1.96%
• 1 month: -10.69%
• 3 months: -5.53%
• 6 months: -13.26%
• Year to date: -2.08%
• 1 year: 22.68%
• 5 years: -1.31%
• 10 years: -37.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32